List of Tables
Table 1. Global Adeno-Associated Virus Vectors in Gene Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Adeno-Associated Virus Vectors in Gene Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Adeno-Associated Virus Vectors in Gene Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg) of Key Manufacturers (2020-2025)
Table 5. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Adeno-Associated Virus Vectors in Gene Therapy Average Price (US$/Kg) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Adeno-Associated Virus Vectors in Gene Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Adeno-Associated Virus Vectors in Gene Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Adeno-Associated Virus Vectors in Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno-Associated Virus Vectors in Gene Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2020-2025) & (Kg)
Table 18. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2026-2031) & (Kg)
Table 20. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg)
Table 27. North America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2026-2031) & (Kg)
Table 28. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg)
Table 32. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2026-2031) & (Kg)
Table 33. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2020-2025) & (Kg)
Table 37. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales by Region (2026-2031) & (Kg)
Table 38. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg)
Table 42. Latin America Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2026-2031) & (Kg)
Table 43. Latin America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2020-2025) & (Kg)
Table 47. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Sales by Country (2026-2031) & (Kg)
Table 48. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg) by Type (2020-2025)
Table 51. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg) by Type (2026-2031)
Table 52. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Type (2020-2025)
Table 59. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Type (2026-2031)
Table 60. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg) by Application (2020-2025)
Table 61. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg) by Application (2026-2031)
Table 62. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Application (2020-2025)
Table 69. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Application (2026-2031)
Table 70. Amicus Therapeutics Company Information
Table 71. Amicus Therapeutics Description and Business Overview
Table 72. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 73. Amicus Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 74. Amicus Therapeutics Recent Developments/Updates
Table 75. Asklepios Biopharmaceutical Company Information
Table 76. Asklepios Biopharmaceutical Description and Business Overview
Table 77. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 78. Asklepios Biopharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product
Table 79. Asklepios Biopharmaceutical Recent Developments/Updates
Table 80. BioMarin Pharmaceutical Company Information
Table 81. BioMarin Pharmaceutical Description and Business Overview
Table 82. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 83. BioMarin Pharmaceutical Adeno-Associated Virus Vectors in Gene Therapy Product
Table 84. BioMarin Pharmaceutical Recent Developments/Updates
Table 85. Coave Therapeutics Company Information
Table 86. Coave Therapeutics Description and Business Overview
Table 87. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 88. Coave Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 89. Coave Therapeutics Recent Developments/Updates
Table 90. MeiraGTx Company Information
Table 91. MeiraGTx Description and Business Overview
Table 92. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. MeiraGTx Adeno-Associated Virus Vectors in Gene Therapy Product
Table 94. MeiraGTx Recent Developments/Updates
Table 95. Neurocrine Biosciences Company Information
Table 96. Neurocrine Biosciences Description and Business Overview
Table 97. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 98. Neurocrine Biosciences Adeno-Associated Virus Vectors in Gene Therapy Product
Table 99. Neurocrine Biosciences Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 103. Pfizer Adeno-Associated Virus Vectors in Gene Therapy Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Roche Holding Company Information
Table 106. Roche Holding Description and Business Overview
Table 107. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 108. Roche Holding Adeno-Associated Virus Vectors in Gene Therapy Product
Table 109. Roche Holding Recent Developments/Updates
Table 110. Sangamo Therapeutics Company Information
Table 111. Sangamo Therapeutics Description and Business Overview
Table 112. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 113. Sangamo Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 114. Sangamo Therapeutics Recent Developments/Updates
Table 115. Sarepta Therapeutics Company Information
Table 116. Sarepta Therapeutics Description and Business Overview
Table 117. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 118. Sarepta Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 119. Sarepta Therapeutics Recent Developments/Updates
Table 120. Spark Therapeutics Company Information
Table 121. Spark Therapeutics Description and Business Overview
Table 122. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 123. Spark Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 124. Spark Therapeutics Recent Developments/Updates
Table 125. Voyager Therapeutics Company Information
Table 126. Voyager Therapeutics Description and Business Overview
Table 127. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 128. Voyager Therapeutics Adeno-Associated Virus Vectors in Gene Therapy Product
Table 129. Voyager Therapeutics Recent Developments/Updates
Table 130. NightstaRx Company Information
Table 131. NightstaRx Description and Business Overview
Table 132. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 133. NightstaRx Adeno-Associated Virus Vectors in Gene Therapy Product
Table 134. NightstaRx Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Adeno-Associated Virus Vectors in Gene Therapy Distributors List
Table 138. Adeno-Associated Virus Vectors in Gene Therapy Customers List
Table 139. Adeno-Associated Virus Vectors in Gene Therapy Market Trends
Table 140. Adeno-Associated Virus Vectors in Gene Therapy Market Drivers
Table 141. Adeno-Associated Virus Vectors in Gene Therapy Market Challenges
Table 142. Adeno-Associated Virus Vectors in Gene Therapy Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
Table 146. Authors List of This Report
List of Figures
Figure 1. Product Picture of Adeno-Associated Virus Vectors in Gene Therapy
Figure 2. Global Adeno-Associated Virus Vectors in Gene Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Adeno-Associated Virus Vectors in Gene Therapy Market Share by Type: 2024 & 2031
Figure 4. Serotype 2 (AVV 2) Product Picture
Figure 5. Synthetic Serotypes Product Picture
Figure 6. Others Product Picture
Figure 7. Global Adeno-Associated Virus Vectors in Gene Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Adeno-Associated Virus Vectors in Gene Therapy Market Share by Application: 2024 & 2031
Figure 9. Alzheimer's Disease
Figure 10. Cystic Dibrosis
Figure 11. Hemophilia B
Figure 12. Parkinson's Disease
Figure 13. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Adeno-Associated Virus Vectors in Gene Therapy Market Size (2020-2031) & (US$ Million)
Figure 15. Global Adeno-Associated Virus Vectors in Gene Therapy Sales (2020-2031) & (Kg)
Figure 16. Global Adeno-Associated Virus Vectors in Gene Therapy Average Price (US$/Kg) & (2020-2031)
Figure 17. Adeno-Associated Virus Vectors in Gene Therapy Report Years Considered
Figure 18. Adeno-Associated Virus Vectors in Gene Therapy Sales Share by Manufacturers in 2024
Figure 19. Global Adeno-Associated Virus Vectors in Gene Therapy Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Adeno-Associated Virus Vectors in Gene Therapy Players: Market Share by Revenue in Adeno-Associated Virus Vectors in Gene Therapy in 2024
Figure 21. Adeno-Associated Virus Vectors in Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Adeno-Associated Virus Vectors in Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2031)
Figure 24. North America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 25. United States Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2031)
Figure 28. Europe Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 29. Germany Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Region (2020-2031)
Figure 36. China Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. China Taiwan Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2031)
Figure 46. Latin America Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Adeno-Associated Virus Vectors in Gene Therapy Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Adeno-Associated Virus Vectors in Gene Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Adeno-Associated Virus Vectors in Gene Therapy by Type (2020-2031)
Figure 56. Global Revenue Market Share of Adeno-Associated Virus Vectors in Gene Therapy by Type (2020-2031)
Figure 57. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Type (2020-2031)
Figure 58. Global Sales Market Share of Adeno-Associated Virus Vectors in Gene Therapy by Application (2020-2031)
Figure 59. Global Revenue Market Share of Adeno-Associated Virus Vectors in Gene Therapy by Application (2020-2031)
Figure 60. Global Adeno-Associated Virus Vectors in Gene Therapy Price (US$/Kg) by Application (2020-2031)
Figure 61. Adeno-Associated Virus Vectors in Gene Therapy Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
